{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:48:06Z","timestamp":1783615686434,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd008994.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000}}],"reference-count":73,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008994.pub3","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T22:22:15Z","timestamp":1606170135000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)"],"prefix":"10.1002","volume":"2020","author":[{"given":"Ussanee S","family":"Sangkomkamhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; Khon Kaen Hospital; Khon Kaen Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisake","family":"Lumbiganon","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Faculty of Medicine; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porjai","family":"Pattanittum","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Faculty of Public Health; Khon Kaen University; Khon Kaen Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD008994.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.jmig.2017.08.585","article-title":"Treatment of abnormal uterine bleeding secondary to uterine fibroids-a pilot, randomized study with dienogest, desogestrel and goserelin acetate","volume":"24 Suppl 1","author":"Brito","year":"2017","journal-title":"Journal of Minimally Invasive Gynecology"},{"issue":"4","key":"10.1002\/14651858.CD008994.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1469-0705.2002.00805.x","article-title":"Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy","volume":"20","author":"Inki","year":"2002","journal-title":"Ultrasound in Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD008994.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.12669\/pjms.304.4219","article-title":"Comparison of levonorgestrel-releasing intrauterine device with oral progestins in heavy menstrual bleeding (HMB) cases with uterine leiomyoma (LNG-IUD and oral progestin usage in myoma uteri )","volume":"30","author":"Tosun","year":"2014","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.fertnstert.2017.05.006","article-title":"Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study","volume":"108","author":"Archer","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0006|cit6","first-page":"119","article-title":"Progesteron preoperative treatment for myomectomy with the intrauterine bigatti shaver (IBS)","volume":"11","author":"Bigatti","year":"2014","journal-title":"Gynecological Surgery"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/humrep\/12.3.436","article-title":"Medroxyprogesterone acetate with zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability","volume":"12","author":"Caird","year":"1997","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub3-BIB0008|cit8","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"Carr BR Stewart EA Archer DF Al-Hendy A Bradley L Watts NB Elagolix alone or with add-back therapy in women with heavy menstrual bleeding and uterine leiomyomas: a randomized controlled trial Obstetrics and Gynecology 2018 Nov;132 5 1252 64 10.1097\/AOG.0000000000002933","DOI":"10.1097\/AOG.0000000000002933"},{"issue":"12","key":"10.1002\/14651858.CD008994.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1471-0528.2007.01545.x","article-title":"A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women","volume":"114","author":"Chan","year":"2007","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1210\/er.2005-0001","article-title":"Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis","volume":"26","author":"Chwalisz","year":"2005","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008994.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"Chwalisz","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0013|cit13","first-page":"341","article-title":"Levonorgestrel intrauterine device reduces uterine fibroid size and improves related symptoms","volume":"6","author":"*Erkay\u0131ran","year":"2018","journal-title":"International Journal of Research (IJR)"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0014|cit14","unstructured":"\u00d6zer A K\u00f6st\u00fc B Pektas MK Levonorgestrel intrauterine device reduces uterine fibroid size and improves related symptoms Journal of The Turkish German Gynecological Association 2016 S226"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0015-0282(16)59763-5","article-title":"A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri","volume":"49","author":"Friedman","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1538-7836.2006.02243.x","article-title":"The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic\/inhibitor systems in women with menorrhagia","volume":"5","author":"Koh","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2011.07.031","article-title":"Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma","volume":"116","author":"Kriplani","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Kulshrestha V Kriplani A Agarwal N Kachhawa G Bhatla N Comparison of efficacy of levonorgestrel intrauterine system (LNG-IUS) in abnormal uterine bleeding due to dysfunctional uterine bleeding, uterine-leiomyoma and adenomyosis International Journal of Gynaecology and Obstetrics 2012 S395","DOI":"10.1016\/S0020-7292(12)60809-1"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3109\/09513590.2015.1128409","article-title":"Dienogest as preoperative treatment of submucous myomas for hysteroscopic surgery: a prospective, randomized study","volume":"32","author":"Lagan\u00e0","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1089\/jwh.2017.6399","article-title":"Dienogest for treatment of endometriosis in Chinese women: a placebo-controlled, randomized, double-blind phase 3 study","volume":"27","author":"Lang","year":"2018","journal-title":"Journal of Women's Health"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0022|cit22","unstructured":"Magalhaes J Magalhaes LB Uterine volume and menstrual patterns in users of LNG-IUS intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas. A cohort prospective study of 8 years European Journal of Contraception and Reproductive Health Care 2010 FC 34"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(01)00588-7","article-title":"Effect of different doses of progestin on uterine leiomyomas in postmenopausal women","volume":"102","author":"Palomba","year":"2002","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD008994.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ajog.2009.10.863","article-title":"Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications","volume":"202","author":"Rodriguez","year":"2010","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0015-0282(16)57729-2","article-title":"Sustained benefits of leuprolide acetate with or without subsequent medroxyprogesterone acetate in the nonsurgical management of leiomyomata uteri","volume":"64","author":"Scialli","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3329\/bjog.v23i1.3054","article-title":"Levonorgestrel intrauterine system Mirena: an update","volume":"23","author":"Siddiqui","year":"2008","journal-title":"Bangladesh Journal of Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(99)00168-2","article-title":"Leuprorelin depot 3.75 mg versus lynestrenol in the preoperative treatment of symptomatic uterine myomas: a multicentre randomised trial","volume":"89","author":"Verspyck","year":"2000","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/oxfordjournals.humrep.a137643","article-title":"Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids","volume":"7","author":"West","year":"1992","journal-title":"Human Reproduction"},{"issue":"12","key":"10.1002\/14651858.CD008994.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2008-1104","article-title":"Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy","volume":"93","author":"Wilkens","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0030-1251483","article-title":"Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth","volume":"28","author":"Yoshida","year":"2010","journal-title":"Seminars in Reproductive Medicine"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0032|cit32","unstructured":"Study of the efficacy of dienogest in the treatment of uterine leiomyomas when compared to desogestrel and goserelin clinicaltrials.gov\/show\/NCT01738724"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0033|cit33","unstructured":"Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2014-003408-65"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/0002-9378(93)90293-R","article-title":"Expression of connexin-43 in human myometrium and leiomyoma","volume":"169","author":"Andersen","year":"1993","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0035|cit35","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"131-8","DOI":"10.1016\/j.ejogrb.2005.06.015","article-title":"Treatment of uterine fibroids by embolization - advantages, disadvantages, and pitfalls","volume":"123","author":"David","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0037|cit37","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Munro MG Critchley HO Broder MS Fraser IS FIGO Working Group on Menstrual Disorders FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age International Journal of Gynaecology and Obstetrics 2011 113 1 3 13","DOI":"10.1016\/j.ijgo.2010.11.011"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environmental Health Perspectives"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"427-31","DOI":"10.1016\/j.cult.2008.09.001","article-title":"Sonohysterography: technique and clinical applications","volume":"3","author":"Glanc","year":"2008","journal-title":"Ultrasound Clinics"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0041|cit41","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"615-26","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0043|cit43","unstructured":"Higgins JPT Altman DG Sterne JC on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbooks"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0044|cit44","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbooks"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1471-0528.1990.tb16249.x","article-title":"Assessment of menstrual blood loss using a pictorial chart","volume":"97","author":"Higham","year":"1990","journal-title":"BR J Obstet Gynaecol"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.steroids.2014.05.002","article-title":"Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review","volume":"86","author":"Jiang","year":"2014","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Kaunitz AM Progestin-releasing intrauterine systems and leiomyoma Contraception 75 6 Suppl S130 3","DOI":"10.1016\/j.contraception.2007.01.012"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0048|cit48","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011) The Cochrane Collaboration. 2011 Available from training.cochrane.org\/handbooks"},{"issue":"4","key":"10.1002\/14651858.CD008994.pub3-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002126.pub3","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding","author":"Lethaby","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008994.pub3-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000547.pub2","article-title":"Preoperative medical therapy before surgery for uterine fibroids","author":"Lethaby","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008994.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study","volume":"103","author":"Lumbiganon","year":"1996","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"193-8","DOI":"10.1016\/j.contraception.2006.11.004","article-title":"Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas","volume":"75","author":"Magalhaes","year":"2007","journal-title":"Contraception"},{"issue":"10-11","key":"10.1002\/14651858.CD008994.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0039-128X(00)00171-9","article-title":"Effects of progesterone on uterine leiomyoma growth and apoptosis","volume":"65","author":"Maruo","year":"2000","journal-title":"Steroids"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"59-67","DOI":"10.1016\/j.ogc.2005.12.001","article-title":"Steroid hormones and leiomyomas","volume":"33","author":"Marsh","year":"2006","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"issue":"3","key":"10.1002\/14651858.CD008994.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Maruo T Ohara N Matsuo H Xu Q Chen W Sitruk-Ware R Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas Contraception 75 6 Suppl S99 103","DOI":"10.1016\/j.contraception.2007.01.025"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0057|cit57","unstructured":"National Institute for Health and Clinical Excellence (NICE) Heavy menstrual bleeding: assessment and management (NG 88) www.nice.org.uk\/guidance\/ng88"},{"issue":"1 Pt 1","key":"10.1002\/14651858.CD008994.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0059|cit59","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"312-24","DOI":"10.1097\/01.grf.0000159538.27221.8c","article-title":"Role, epidemiology, and natural history of benign uterine mass lesions","volume":"48","author":"Ryan","year":"2005","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"235-41","DOI":"10.1097\/00004347-198609000-00005","article-title":"Endometrial morphology during long-term use of levonorgestrel-releasing intrauterine devices","volume":"5","author":"Silverberg","year":"1986","journal-title":"International Journal of Gynecological Pathology"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0062|cit62","unstructured":"Sterne JA Egger M Moher D Boutron I Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from training.cochrane.org\/handbooks"},{"issue":"10","key":"10.1002\/14651858.CD008994.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"807-16","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"Journal of Women's Health"},{"issue":"10","key":"10.1002\/14651858.CD008994.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"364-71","DOI":"10.1097\/00003081-200106000-00022","article-title":"Clinical symptomatology of uterine leiomyomas","volume":"44","author":"Stovall","year":"2001","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"9","key":"10.1002\/14651858.CD008994.pub3-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008994.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1080\/02664763.2017.1391180","article-title":"Untangle the structural and random zeros in statistical modelings","volume":"45","author":"Tang","year":"2018","journal-title":"Journal of Applied Statistics"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0068|cit68","unstructured":"Department of Economic and Social Affairs World Contraceptive Use 2020 (POP\/DB\/CP\/Rev2020) Available at www.un.org\/en\/development\/desa\/population\/publications\/dataset\/contraception\/wcu2020.asp 2020"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0069|cit69","unstructured":"World Health Organization (WHO) Medical eligibility criteria for contraceptive use Available at www.who.int\/reproductivehealth\/publications\/family_planning\/MEC-5\/en\/ 2015"},{"key":"10.1002\/14651858.CD008994.pub3-BIB0070|cit70","unstructured":"World Health Organization (WHO) Family planning: a global handbook for providers (2018 update) Available at www.who.int\/reproductivehealth\/publications\/fp-global-handbook\/en\/ 2018"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2010.02.011","article-title":"Intrauterine device use among women with uterine fibroids: a systematic review","volume":"82","author":"Zapata","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD008994.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Women's Health"},{"issue":"2","key":"10.1002\/14651858.CD008994.pub3-BIB0073|cit73","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008994.pub2","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T08:14:54Z","timestamp":1687853694000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008994.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":73,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008994.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]}}}